alpha-cyano-4-hydroxycinnamate has been researched along with Adenocarcinoma in 1 studies
alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A | 1 |
| Kant, S | 1 |
| Singh, SM | 1 |
1 other study available for alpha-cyano-4-hydroxycinnamate and Adenocarcinoma
| Article | Year |
|---|---|
Targeting monocarboxylate transporter by α-cyano-4-hydroxycinnamate modulates apoptosis and cisplatin resistance of Colo205 cells: implication of altered cell survival regulation.
Topics: Adenocarcinoma; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; | 2013 |